Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV

NCT05495906 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT05495906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05495906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV
Lead sponsor
University of British Columbia
Phase
Phase 4
Overall status
Recruiting
Start date
July 27, 2023
Completion date
January 31, 2028
Enrollment
275 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hpv, human immunodeficiency virus, human papilloma virus